Effect of High Intensity Laser on Hemiplegic Shoulder Dysfunction
1 other identifier
interventional
44
1 country
1
Brief Summary
Hemiplegic shoulder pain (HSP) is a common and disabling complication following a stroke, and it may affect the quality of life. It often occurs following two to three months of stroke. Upper limb impairment is seen in 90% of patients affected by stroke. Numerous causes have been implicated in developing HSP in stroke. This includes muscle flaccidity around the shoulder joint, shoulder subluxation, shoulder-hand syndrome, increased muscle tone, impingement syndrome, frozen shoulder, brachial plexus injury, and the thalamic syndrome. Muscle paresis, abnormal muscle tone and loss of proprioception following stroke may render the shoulder complex unstable and therefore prone to misalignment. In recent years, high-intensity laser therapy (HILT) has been considered as a treatment option for shoulder pain. HILT increases microcirculation and tissue regeneration and lowers edema, inflammation, and pain with its photomechanical, thermal, electrical, and bio stimulating effects in deep tissues that cannot be reached with LILT. It has some advantages over LILT, i.e., having higher power, greater tissue penetration capacity to deep tissues, the short emission time, and long rest periods preventing heat accumulation. In recent studies, effectiveness of HILT has been shown in the treatment of subacromial impingement syndrome, rotator cuff tendinopathy, and frozen shoulder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1 stroke
Started Oct 2022
Shorter than P25 for phase_1 stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 17, 2022
CompletedStudy Start
First participant enrolled
October 20, 2022
CompletedFirst Posted
Study publicly available on registry
October 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2023
CompletedSeptember 26, 2023
September 1, 2023
3 months
October 17, 2022
September 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
PAIN score
McGill pain questioner scale, scoring from zero to 78 zero is the best score seventy eight is the worst score
1 MONTH
FUNCTION
UCLA shoulder score from zero to 35 zero is the worst 35 is the best
1 MONTH
Study Arms (2)
treatment group
EXPERIMENTALcontrol group
NO INTERVENTIONInterventions
7W(LAZR-207)/15W(LAZR-215\&115)HIGH POWER LASER THERAPYUNIT WITH 2 WAVELENGTHMODES,COMBINATION(810+980 NM) AND SINGLE(1064 NM)
Eligibility Criteria
You may qualify if:
- DISORDER MORE THAN 6 MONTHS
- UNILATERAL
- FIRST TIME
You may not qualify if:
- Iinflammatory rheumatic disease,
- cervical radiculopathy,
- diabetes mellitus,
- thyroid disease,
- coronary heart disease,
- cardiac pacemaker,
- neurological disease,
- shoulder surgery, and
- shoulder injection in the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Physical Therapy
Minya, Minya Governorate, 05673, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 17, 2022
First Posted
October 27, 2022
Study Start
October 20, 2022
Primary Completion
January 18, 2023
Study Completion
January 20, 2023
Last Updated
September 26, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will share